Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Santos-Laso

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Hepatology|May 13, 2017
O-GlcNAcylation: Undesired tripmate but an opportunity for treatment in NAFLD-HCCAlvaro Santos-Laso, María J Perugorria, Jesús M Banales
Journal of Hepatology|October 28, 2023
Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settingsPaula Iruzubieta, Alvaro Santos-Laso, María Teresa Arias-Loste, et al.
Journal of Hepatology|September 9, 2018
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?Pedro M Rodrigues, Maria J Perugorria, Alvaro Santos-Laso, et al.
Current Drug Targets|April 28, 2015
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular TargetsAlvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, et al.
International Journal of Molecular Sciences|July 14, 2023
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is KeyMarta Alonso-Peña, Maria Del Barrio, Ana Peleteiro-Vigil, et al.
Biomedicines|January 21, 2022
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to TargetsAlvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, et al.
Liver Cancer|December 24, 2021
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?María Gutiérrez-Larrañaga, Elena González-López, Adriel Roa-Bautista, et al.
International Journal of Molecular Sciences|May 13, 2023
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive ReviewAitor Odriozola, Alvaro Santos-Laso, María Del Barrio, et al.
Clinics in Liver Disease|April 6, 2023
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver DiseaseJeffrey V Lazarus, Marcela Villota-Rivas, Carolina Jiménez-González, et al.
Hepatology (Baltimore, Md.)|May 17, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Hepatology|May 13, 2017
O-GlcNAcylation: Undesired tripmate but an opportunity for treatment in NAFLD-HCCAlvaro Santos-Laso, María J Perugorria, Jesús M Banales
Journal of Hepatology|October 28, 2023
Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settingsPaula Iruzubieta, Alvaro Santos-Laso, María Teresa Arias-Loste, et al.
Journal of Hepatology|September 9, 2018
Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?Pedro M Rodrigues, Maria J Perugorria, Alvaro Santos-Laso, et al.
Current Drug Targets|April 28, 2015
New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular TargetsAlvaro Santos-Laso, Patricia Munoz-Garrido, Maialen Felipe-Agirre, et al.
International Journal of Molecular Sciences|July 14, 2023
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is KeyMarta Alonso-Peña, Maria Del Barrio, Ana Peleteiro-Vigil, et al.
Biomedicines|January 21, 2022
Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to TargetsAlvaro Santos-Laso, María Gutiérrez-Larrañaga, Marta Alonso-Peña, et al.
Liver Cancer|December 24, 2021
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?María Gutiérrez-Larrañaga, Elena González-López, Adriel Roa-Bautista, et al.
International Journal of Molecular Sciences|May 13, 2023
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive ReviewAitor Odriozola, Alvaro Santos-Laso, María Del Barrio, et al.
Clinics in Liver Disease|April 6, 2023
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver DiseaseJeffrey V Lazarus, Marcela Villota-Rivas, Carolina Jiménez-González, et al.
Hepatology (Baltimore, Md.)|May 17, 2021
REPLYAngela Lamarca, Alvaro Santos-Laso, Kirsten Utpatel, et al.
Pageof 3